Vanguard Group’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.99M | Sell |
1,835,649
-157,111
|
|
||||
|
2025
Q1 | $5.24M | Sell |
1,992,760
-115,697
|
|
||||
|
2024
Q4 | $7.46M | Buy |
2,108,457
+399,511
|
|
||||
|
2024
Q3 | $7.79M | Buy |
1,708,946
+322,750
|
|
||||
|
2024
Q2 | $6.03M | Buy |
1,386,196
+16,360
|
|
||||
|
2024
Q1 | $6.88M | Sell |
1,369,836
-52
|
|
||||
|
2023
Q4 | $8.59M | Buy |
1,369,888
+150,871
|
|
||||
|
2023
Q3 | $8.68M | Buy |
1,219,017
+26,011
|
|
||||
|
2023
Q2 | $12.2M | Buy |
1,193,006
+193,039
|
|
||||
|
2023
Q1 | $9.07M | Buy |
999,967
+122,959
|
|
||||
|
2022
Q4 | $6.29M | Buy |
877,008
+260,450
|
|
||||
|
2022
Q3 | $4.02M | Hold |
616,558
|
|
||||
|
2022
Q2 | $2.97M | Hold |
616,558
|
|
||||
|
2022
Q1 | $3.5M | Hold |
616,558
|
|
||||
|
2021
Q4 | $3.1M | Sell |
616,558
-490
|
|
||||
|
2021
Q3 | $4.1M | Buy |
617,048
+8,100
|
|
||||
|
2021
Q2 | $3.72M | Sell |
608,948
-34,507
|
|
||||
|
2021
Q1 | $4.28M | Buy |
643,455
+8,491
|
|
||||
|
2020
Q4 | $3.36M | Buy |
634,964
+45,288
|
|
||||
|
2020
Q3 | $4.39M | Buy |
589,676
+2,077
|
|
||||
|
2020
Q2 | $4.33M | Buy |
587,599
+343,634
|
|
||||
|
2020
Q1 | $1.8M | Sell |
243,965
-12,168
|
|
||||
|
2019
Q4 | $1.45M | Hold |
256,133
|
|
||||
|
2019
Q3 | $1.52M | Buy |
256,133
+167,172
|
|
||||
|
2019
Q2 | $284K | Sell |
88,961
-71,735
|
|
||||
|
2019
Q1 | $482K | Sell |
160,696
-86
|
|
||||
|
2018
Q4 | $604K | Sell |
160,782
-45,137
|
|
||||
|
2018
Q3 | $1.21M | Sell |
205,919
-3,339
|
|
||||
|
2018
Q2 | $1.18M | Buy |
209,258
+6,314
|
|
||||
|
2018
Q1 | $2.52M | Buy |
202,944
+22,944
|
|
||||
|
2017
Q4 | $2.18M | Buy |
+180,000
|
|